Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Angela Rivers, MD, PhD
Researcher Assistant Professor
Division of Hematology/Oncology
University of Illinois College of Medicine
Outpatient Care Center, Suite 2E
1801 West Taylor Street
Chicago, Illinois, United States
Dr. Rivers is the Director at Sickle Cell Transition Adolescent-Adult Readiness Clinic (STAR) program. Her research interests focus on the Adeno Associated Virus as a vector for gene therapy in sickle cell disease. She has received NIH K08 funding for lab research inducers of fetal hemoglobin. The research (K01 HL103172-01, NIH/ NIHLBI) led by Dr. Rivers focuses on AAV capsid engineering to facilitate expression of therapeutic levels of beta-globin in mouse hematopoietic stem cells. Because everyone is not a candidate for transplantation, successful treatment for sickle cell disease needs to include the development of therapeutic options beside hydroxyurea. Under the mentorship of Dr. Don Lavelle and Dr. Joseph De Simone at the University of Illinois Chicago, the research of Dr. Rivers also focuses on the possible phenotypic correction of sickle disease by induction of hemoglobin F with the combination treatment of Decitabine and novel drugs.
Representative Publications:
Related Content
-
Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful CrisesOBJECTIVES: Sickle cell disease is the ...
-
Sylvia Benjamin, MB, BS, FRCP, FRCPathSylvia Benjamin is Consultant in Haemato...
-
Practice variation in emergency department management of children with sickle cell disease who present with feverOBJECTIVES:Urgent medical evaluation is ...
-
The Brookdale University Hospital and Medical CenterThe Comprehensive Pediatric Sickle Cell ...
-
Spencer Wood, MSSpencer Wood is a certified genetic coun...
-
Vaso occlusive Crisis Pain Assessment & Managementhttps://www.youtube.com/watch?time_conti...
-
Patients With Sickle Cell Disease may Have Lower Risk for C. DifficileFindings from a retrospective cohort stu...